| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3976791 | Brachytherapy | 2015 | 7 Pages |
Abstract
BT utilization for nonsurgically managed endometrial cancer remains low with most patients receiving EBRT alone. Despite concerns of overtreatment in a population with competing causes of death, BT appears to improve survival.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Beant S. Gill, Bhavana V. Chapman, Karyn J. Hansen, Paniti Sukumvanich, Sushil Beriwal,